Eliezer Masliah, M.D.

Professor of Neuroscience and Pathology

Dr. Eliezer Masliah, M.D.
E-mail: emasliah@ucsd.edu
 

Education:

National Autonomous University of Mexico City, Mexico 1983 M.D.

Professional Experience:

1983-1984 Resident, General Pathology, National Institute of Nutrition, Mexico City, Mexico
1984-1985 Resident, Oncologic Pathology, National Institute of Cancerology, Mexico City, Mexico
1985-1986 Resident, Pediatric Pathology, National Institute of Pediatrics, Mexico City, Mexico
1988-1990 Postdoctoral Fellow, Pathology of Neurodegenerative Diseases, University of California San Diego, La Jolla, CA
1990-1991 Assistant Research Neuroscientist, University of California San Diego, La Jolla, CA
1991-1993 Assistant Professor, Departments of Neurosciences and Pathology, University of California San Diego, La Jolla, CA
1993-1996 Associate Professor, Departments of Neurosciences and Pathology, University of California San Diego, La Jolla, CA
1997-present ResidentDepartments of Neurosciences and Pathology, University of California San Diego, La Jolla, CA
1995-present Director of Autopsy Service, Department of Pathology, University of California San Diego Medical Center, San Diego, California

Honors:

1989 Weil Award (Honorable Mention), American Association of Neuropathologists
1990 Alzheimer Association/George F. Berlinger Faculty Scholar Award
Neil Award (Honorable Mention), American Association of Neuropathologists

Recent Publications:

Link to PUB MED Results

  1. Masliah E, Hansen L, Adame A, Crews L, Bard F, Lee C, Seubert P, Games D, Kirby L, Schenk D.
    * Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. Neurology. 64:129-31, 2005.
  2. Rockenstein E, Adame A, Mante M, Larrea G, Crews L, Windisch M, Moessler H, Masliah E.
    * Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound Cerebrolysintrade mark. J Neural Transm. 112:269-82, 2005.
  3. Ho GJ, Hashimoto M, Adame A, Izu M, Alford MF, Thal LJ, Hansen LA, Masliah E.
    * Altered p59(Fyn) kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role. Neurobiol Aging. 26:625-35, 2005.
  4. Langford D, Hurford R, Hashimoto M, Digicaylioglu M, Masliah E.
    *Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120. BMC Neurosci. 6:8, 2005.
  5. Rockenstein E, Schwach G, Ingolic E, Adame A, Crews L, Mante M, Pfragner R, Schreiner E, Windisch M, Masliah E.
    * Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein. J Neurosci Res. 80:247-59, 2005.
  6. Masliah E, Rockenstein E, Adame A, Alford M, Crews L, Hashimoto M, Lee M, Chilcote T, Games D, Schenck D.
    *Effects of α-synuclein immunizations in a mouse model of Parkinson’s disease. Neuron. 46:857-68, 2005.
  7. Rockenstin E, Mante M, Alford M, Adame A, Crews L, Hashimoto M, Maya S, Esposito L, Mucke L, Masliah E.
    * High β-secretase activity elicits neurodegeneration in transgenic mice and despite reductions in amyloid-β levels: implications for the treatment of Alzheimer’s Disease. J. Biol. Chem. 280:32957-67, 2005
  8. Singer O, Marr R, Rockenstein E, Crews L, Gage F, Verma I, Masliah E.
    * Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nature Neuroscience. 2005 8:1343-9, 2005